Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.88 -0.02 (-1.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lexicon Pharmaceuticals (LXRX) Common Equity (2010 - 2026)

Updated

Lexicon Pharmaceuticals (LXRX) reported Common Equity of $174.53 million for Q2 2026, up 34.8% from $129.44 million a year earlier but down 14.0% from the prior quarter.

Analysis

Lexicon Pharmaceuticals (LXRX) Common Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Lexicon Pharmaceuticals posted Common Equity of $107.54 million, down 26.3% from FY2024.

  • Common Equity has a five-year compound annual growth rate of -7.2% (FY2020 to FY2025).
  • By year, Common Equity came in at $145.95 million in FY2024 (+56.8%), $93.11 million in FY2023 (-20.5%), $117.12 million in FY2022 (+3.1%) and $113.6 million in FY2021 (-27.4%).
  • Five-year quarterly Common Equity spans a low of $70.83 million in Q2 2022 and a high of $288.87 million in Q1 2024.
  • Year over year, Common Equity gained in four of the last eight quarters, with growth averaging 2.7%.
  • The high point for year-over-year Common Equity in five years was Q1 2024 (growth of 228.1%); the low point was Q1 2025 (a decline of 57.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $202.86 million (Q1 2026), $107.54 million (Q4 2025) and $120.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Lexicon Pharmaceuticals 849.05 Mn 275.61 Mn 653,000.00 174.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 174.53 Mn
Mar 31, 2026 202.86 Mn
Dec 31, 2025 107.54 Mn
Sep 30, 2025 120.16 Mn
Jun 30, 2025 129.44 Mn
Mar 31, 2025 123.03 Mn
Dec 31, 2024 145.95 Mn
Sep 30, 2024 178.51 Mn
Jun 30, 2024 239.98 Mn
Mar 31, 2024 288.87 Mn
Dec 31, 2023 93.11 Mn
Sep 30, 2023 139.51 Mn
Jun 30, 2023 186.36 Mn
Mar 31, 2023 88.05 Mn
Dec 31, 2022 117.12 Mn
Sep 30, 2022 144.02 Mn
Jun 30, 2022 70.83 Mn
Mar 31, 2022 92.70 Mn
Dec 31, 2021 113.60 Mn
Sep 30, 2021 136.60 Mn
API Access

Lexicon Pharmaceuticals Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=LXRX&period=max&api_key=YOUR_API_KEY